Related Experiment Video
Updated: Jun 19, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
Published on: October 17, 2025
Moxifloxacin induced fatal hepatotoxicity in a 72-year-old man: a case report
Rajanshu Verma1, Radhika Dhamija, Donald H Batts
1Department of Internal Medicine, Michigan State University/KCMS 1000 Oakland Dr, Kalamazoo, Michigan 49008 USA. rverma@kcms.msu.edu
Abstract:
Moxifloxacin is a newer-generation synthetic fluoroquinolone that is used for treatment of acute bacterial sinusitis, acute exacerbation of chronic bronchitis, community acquired pneumonia, intra-abdominal infections and skin/skin structure infections. We describe a case of fatal hepatotoxicity caused by Moxifloxacin in a 72-year-old man. He presented with jaundice and epigastric tenderness that started one week after being treated for acute exacerbation of his chronic bronchitis with Moxifloxacin by his primary care physician. He was admitted to intensive care unit for close monitoring. His labs showed marked elevation in liver enzymes and bilirubin. His condition continued to deteriorate in intensive care unit despite supportive care. Acute hepatic failure which resulted in his death was attributed to idiosyncratic reaction to Moxifloxacin.
Related Concept Videos
Drug Toxicity: Risk factors
Inhibitors of Bacterial DNA Synthesis
Drug toxicity: Idiosyncratic Reactions
Drug Toxicity: Overview
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Toxicity: Allergic Reactions